Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updates appear to be limited to metadata changes (dates, references); core study content remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:13.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    4%
    Check dated 2025-10-05T10:29:36.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:34.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2. The old revision label was removed and the Back to Top element was dropped; no other core content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-13T17:39:02.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-06T15:18:01.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include specific facility names and locations in South Korea, along with a new reference to a clinical trial involving the GX-188 vaccine and pembrolizumab. The revision number has also been updated.
    Difference
    7%
    Check dated 2025-08-30T11:49:25.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.